MEDIF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Dec 18 closing price
NDVAF
Price
$0.02
Change
-$0.01 (-33.33%)
Updated
Jun 12 closing price
Ad is loading...

MEDIF vs NDVAF

Header iconMEDIF vs NDVAF Comparison
Open Charts MEDIF vs NDVAFBanner chart's image
Medipharm Labs
Price$0.05
Change-$0.00 (-0.00%)
Volume$115.15K
CapitalizationN/A
Indiva
Price$0.02
Change-$0.01 (-33.33%)
Volume$510.99K
CapitalizationN/A
MEDIF vs NDVAF Comparison Chart
Loading...
MEDIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MEDIF vs. NDVAF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDIF is a Hold and NDVAF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (MEDIF: $0.05 vs. NDVAF: $0.02)
Brand notoriety: MEDIF and NDVAF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MEDIF: 81% vs. NDVAF: 100%
Market capitalization -- MEDIF: $19.13M vs. NDVAF: $3.51M
MEDIF [@Pharmaceuticals: Other] is valued at $19.13M. NDVAF’s [@Pharmaceuticals: Other] market capitalization is $3.51M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MEDIF’s FA Score shows that 0 FA rating(s) are green whileNDVAF’s FA Score has 0 green FA rating(s).

  • MEDIF’s FA Score: 0 green, 5 red.
  • NDVAF’s FA Score: 0 green, 5 red.
According to our system of comparison, both MEDIF and NDVAF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MEDIF’s TA Score shows that 2 TA indicator(s) are bullish.

  • MEDIF’s TA Score: 2 bullish, 7 bearish.

Price Growth

MEDIF (@Pharmaceuticals: Other) experienced а -8.73% price change this week, while NDVAF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.75%. For the same industry, the average monthly price growth was +1.64%, and the average quarterly price growth was -9.20%.

Industries' Descriptions

@Pharmaceuticals: Other (+0.75% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MEDIF($19.1M) has a higher market cap than NDVAF($3.51M). MEDIF YTD gains are higher at: -6.481 vs. NDVAF (-67.266). NDVAF has higher annual earnings (EBITDA): -5.09M vs. MEDIF (-41.42M). MEDIF has more cash in the bank: 20.2M vs. NDVAF (2.82M). MEDIF has less debt than NDVAF: MEDIF (218K) vs NDVAF (21.9M). NDVAF has higher revenues than MEDIF: NDVAF (34.9M) vs MEDIF (22.2M).
MEDIFNDVAFMEDIF / NDVAF
Capitalization19.1M3.51M544%
EBITDA-41.42M-5.09M814%
Gain YTD-6.481-67.26610%
P/E RatioN/AN/A-
Revenue22.2M34.9M64%
Total Cash20.2M2.82M715%
Total Debt218K21.9M1%
FUNDAMENTALS RATINGS
MEDIF vs NDVAF: Fundamental Ratings
MEDIF
NDVAF
OUTLOOK RATING
1..100
5549
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9599
PRICE GROWTH RATING
1..100
6375
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NDVAF's Valuation (88) in the null industry is in the same range as MEDIF (91). This means that NDVAF’s stock grew similarly to MEDIF’s over the last 12 months.

NDVAF's Profit vs Risk Rating (100) in the null industry is in the same range as MEDIF (100). This means that NDVAF’s stock grew similarly to MEDIF’s over the last 12 months.

MEDIF's SMR Rating (95) in the null industry is in the same range as NDVAF (99). This means that MEDIF’s stock grew similarly to NDVAF’s over the last 12 months.

MEDIF's Price Growth Rating (63) in the null industry is in the same range as NDVAF (75). This means that MEDIF’s stock grew similarly to NDVAF’s over the last 12 months.

MEDIF's P/E Growth Rating (100) in the null industry is in the same range as NDVAF (100). This means that MEDIF’s stock grew similarly to NDVAF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MEDIFNDVAF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 16 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
MEDIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LUXH1.010.16
+18.82%
LuxUrban Hotels Inc
CHEF47.55-1.37
-2.80%
Chefs' Warehouse (The)
PH643.80-22.19
-3.33%
Parker-Hannifin Corp
MTG23.38-0.91
-3.75%
MGIC Investment Corp
MTRX12.30-0.79
-6.04%
Matrix Service Company

MEDIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MEDIF has been loosely correlated with CGC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MEDIF jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDIF
1D Price
Change %
MEDIF100%
-0.33%
CGC - MEDIF
36%
Loosely correlated
-7.21%
TLRY - MEDIF
28%
Poorly correlated
-6.45%
ACB - MEDIF
24%
Poorly correlated
-5.15%
AAWH - MEDIF
24%
Poorly correlated
+8.94%
GLASF - MEDIF
24%
Poorly correlated
-1.19%
More

NDVAF and

Correlation & Price change

A.I.dvisor tells us that NDVAF and MEDIF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NDVAF and MEDIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NDVAF
1D Price
Change %
NDVAF100%
N/A
MEDIF - NDVAF
9%
Poorly correlated
-0.33%
MRMD - NDVAF
4%
Poorly correlated
+10.21%
OASMY - NDVAF
2%
Poorly correlated
N/A
OILFF - NDVAF
1%
Poorly correlated
-4.43%
MGWFF - NDVAF
1%
Poorly correlated
+0.42%
More